The inspection, which took place from April 25 to May 3, was conducted at the Bhiwadi facility in Rajasthan’s Alwar.

Aurobindo Pharma Facility Receives ‘Official Action Indicated’ Classification From USFDA

Q1 earnings cheer: Lupin, Zydus Lifesciences, Glenmark Pharmaceuticals, Aurobindo Pharma, Torrent Pharmaceuticals and Sun Pharmaceutical were up between 2 per cent and 3 per cent.

Pharma shares rally; Suven, Granules, Ajanta, Jubilant surge over 5%

Companies such as Welspun Living and Aurobindo Pharma have already announced share buybacks, while AIA Engineering, Savita Oil Technologies, and Cera Sanitaryware are scheduled to hold board meetings to consider similar actions.

Raining Buybacks: 6 companies announce buybacks post Budget. More to follow?

Big Pharma companies Cipla, Sun Pharma, Aurobindo Pharma, Dr Reddy’s, and Lupin face intense scrutiny from the US Food and Drug Administration (USFDA)

USFDA scrutiny delays generic drug approvals for major Indian pharma firms

Aurobindo Pharma Ltd is quoting at Rs 1402.55, up 1.18% on the day as on 12:49 IST on the NSE. The stock is up 70.57% in last one year as compared to a 25.95% gain in NIFTY and a 44.08% gain in the Nifty Pharma index.

Aurobindo Pharma Ltd spurts 1.18%, rises for third straight session

Aurobindo Pharma on Thursday said its board has approved a share buyback plan of up to Rs 750 crore.

Aurobindo Pharma board approves share buyback plan worth Rs 750 cr

Aurobindo Pharma plans to buy back shares at a premium, offering ₹1,460 each to eligible equity shareholders.

Aurobindo Pharma board gives nod for ₹750 cr. buyback of 51.37 lakh shares at ₹1,460 each

Aurobindo Pharma board approved share buyback of up to Rs 750 crore at a price of Rs 1,460 per equity share.

Auro Pharma board OKs Rs 750-cr share buyback

Aurobindo Pharma shares rise 3.53% on buyback hint, closing at ₹1,373.85 on BSE; board to meet on July 18.

Aurobindo Pharma gains 3.5% on buyback plans

We put the spotlight on top movers & shakers of the day. Stocks in focus: Aurobindo Pharma, Bank Of Maharashtra, IREDA. Take a quick check-in on the top corporate voices of the day & events to watch out for tomorrow’s trading session.

Keep a track on all the data points to prepare for the next trading day with Mayuresh Joshi of William O'Neil & Shilpa Rout of Prabhudas Lilladher

#aurobindopharma #bankofmaharashtra #ireda #dstreet #dalalstreet #sensex #nifty #stockmarket #stockmarketnews #stockmarketupdates #cnbctv18  #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday 

🔴CNBC TV18 LIVE TV: https://youtube.com/live/P857H4ej-MQ
SUBSCRIBE to our Channel: https://bit.ly/3nvEcxf
---------------------------------------------------------------------------------------------------------------------
👑 Check Out Top CNBC TV18 Playlist Videos: 
   
🔹Lok Sabha Elections 2024: https://www.youtube.com/playlist?list=PLjq9mRS1PfGC0rKWJ57LWAs_ytML7x4CD

🔹CNBC TV18 Digital Podcast: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCUcGVQvYyDQ6VVHoo3ZDKJ

🔹Sounding Board: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBbB2dV2tyHdzx_k9EqvVEm 

🔹International Videos: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDZ-Dkz-VpCDqqmWThJ3YJw

🔹CNBC TV18 Market Cafe: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDANftdnJchuL-WPpSv5rmH

🔹CNBC TV18 Digital: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDLhtM8FzErPcjmJRQ4I5cZ

🔹CNBC TV18 Weekend Special: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBHEa5NnoKuUsX5GwxEGuri

🔹CNBC TV18 Next-Gen: https://www.youtube.com/playlist?list=PLjq9mRS1PfGA6roe9q3J9fq_gBIDjX2w7

🔹Overdrive Show: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCnSVjfbWfNCJLrv-CqfGmH

🔹Young Turks: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBZaN1e38X2ZmevnU1e1NJs

🔹Starup Streets: https://www.youtube.com/playlist?list=PLjq9mRS1PfGD3CzrtMr_VJRbIly6sfyFI

------------------------------------------------------------------------------------
You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News
Follow us on Instagram: https://www.instagram.com/cnbctv18india/
Catch us on: Linkedin: https://in.linkedin.com/company/cnbc-tv18
n18oc_business

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.

Look Ahead To Tomorrow's Trade: What Are Key Events, Stocks To Watch | Markets Forward | CNBC TV18

Aurobindo Pharma gains 3.53% on BSE, plans share buyback; reports 79.6% profit growth in Q4 FY24.

Aurobindo Pharma scrip gains 3.53% on share buyback move

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs).

Aurobindo Pharma Ltd